您的位置: 专家智库 > >

重庆市卫生局医学科研项目(2011-2-344)

作品数:2 被引量:4H指数:1
相关作者:吴诚义周鑫更多>>
相关机构:重庆医科大学附属第一医院更多>>
发文基金:重庆市卫生局医学科研项目更多>>
相关领域:医药卫生生物学更多>>

文献类型

  • 2篇中文期刊文章

领域

  • 2篇医药卫生
  • 1篇生物学

主题

  • 2篇乳腺
  • 1篇多态
  • 1篇多态性
  • 1篇药物
  • 1篇乳腺癌
  • 1篇乳腺肿
  • 1篇乳腺肿瘤
  • 1篇肿瘤
  • 1篇蒽环类
  • 1篇蒽环类药
  • 1篇蒽环类药物
  • 1篇腺癌
  • 1篇腺肿瘤
  • 1篇疗效
  • 1篇敏感性
  • 1篇类药
  • 1篇类药物
  • 1篇化疗
  • 1篇化疗敏感
  • 1篇化疗敏感性

机构

  • 1篇重庆医科大学...

作者

  • 1篇周鑫
  • 1篇吴诚义

传媒

  • 1篇吉林大学学报...
  • 1篇中华内分泌外...

年份

  • 1篇2013
  • 1篇2012
2 条 记 录,以下是 1-2
排序方式:
CD44基因多态性与乳腺癌对蒽环类药物化疗敏感性的关系被引量:4
2012年
目的:研究CD44基因rs4756195位点不同基因型乳腺癌患者对蒽环类药物化疗敏感性的差异,阐明CD44基因多态性与乳腺癌对蒽环类药物化疗敏感性的关系。方法:利用Sequenom MassArrayRiPLEX GOLD系统检测120例接受以蒽环类药物为基础的新辅助化疗的乳腺癌患者CD44基因rs4756195位点多态性,2~3个治疗周期后,以非条件Logistic回归模型比较携带不同基因型的乳腺癌患者之间化疗总有效率和病理完全缓解率的差异。结果:携带GG基因型与携带AA和AG基因型的乳腺癌患者术前新辅助化疗总有效率差异无统计学意义(73.6%vs 69.0%,χ2=0.240,P=0.625);携带AA和AG基因型的乳腺癌患者的病理完全缓解率明显高于携带GG基因型的乳腺癌患者(55.2%vs 16.5%,χ2=17.181,P=0.000;OR=13.935,95%CI=4.359~44.541,P=0.000)。结论:CD44基因rs4756195位点多态性与乳腺癌对蒽环类药物的化疗敏感性有关联,携带AA和AG基因型的乳腺癌患者有较高的病理完全缓解率,提示CD44基因rs4756195位点多态性可能成为预测乳腺癌化疗疗效的指标之一。
周鑫吴诚义
关键词:乳腺肿瘤CD44基因基因多态性化疗敏感性
Secretory breast carcinoma in a 10 years old boy
2013年
1 Introduction Secretory breast carcinoma(SBC) is a rare(< 1%) type of breast carcinoma,which was initially termed "Juvenile breast cancer" by McDivitt and Stewart,based on the fact that the average age of the 7 patients described in their report was 9 years old with a range of 3 to 15 years[1].It is most common under the age of 30,and it is the most common type of breast carcinoma in children[2].Although firstly described in children and adolescents,it is now known to occur in adults of both sexes[3],and male to female ratio is 1:6[4].The tumor is the only epithelial tumor of the breast with a balanced translocation,t (12;15),that creates an ETV6-NTRK3 gene translocation[3].The biological consequence of this translocation is the fusion of the dimerization domain of a transcriptional regulator (ETV6)with a membrane receptor tyrosine kinase (NTRK3) that activates the RasMekl and PI3K-Akt pathways which are important for breast cell proliferation and survival.This specific translocation is associated with congenital fibrosarcoma and mesoblastic nephroma,2 morphologically similar pediatric mesenchymal tumors with no epithelial features[5].
ZHOU Xin
关键词:乳腺癌疗效
共1页<1>
聚类工具0